That Funky Cold Moderna Drives Markets Higher
Global equity markets soared on Monday as headlines surrounding Moderna’s phase-1 trial results for a COVID-19 vaccine proved promising. J.P. Morgan’s Biotech analysts offered there reaction and analysis to clients in a note on Monday as follows: Quick Takes from the Conference Call: The neutralizing titers seen from the Phase 1 results were consistent with…
